According to Morgan Stanley, CIGNA CI story is evolving away from traditional multi-line structure.
Morgan Stanley said that even against a challenging backdrop over the last few years, CI has made progress in expanding its breadth, strengthening its capital position, and repositioning the business. “We like CI's strategy to drive targeted, deliberate growth in certain healthcare segments and expand internationally. Stepping back, we currently favor plans with greater scale and sustained cost advantages (i.e., UNH, WLP, CVH) as we look toward the evolving system post-reform.”
CIGNA closed yesterday at $47.72.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in